Test Price
2,800 AED✅ Home Collection Available
TUBGCP6 Gene Microcephaly, Chorioretinopathy & Intellectual Disability Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين TUBGCP6 لصغر الرأس واعتلال الشبكية المشيمية والإعاقة الذهنية في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
99.9% Diagnostic Sensitivity
NGS with full gene coverage & ISO 9001:2015 certified laboratory (Cert: INT/EGQ/2509DA/3139)
دقة تشخيصية ٩٩.٩٪ بمعالجة مخبرية معتمدة من الآيزو
Premium Hospital‑Grade Home Collection
ISO‑certified cold‑chain logistics & VIP mobile phlebotomy, 8 AM – 11 PM
سحب عينات منزلي بمعايير المستشفيات وسلسلة تبريد معتمدة
Post‑Test Clinical Guidance
Telephonic interpretation support by DHA‑licensed clinical geneticists
استشارة هاتفية بعد النتيجة مع أخصائيي الوراثة السريرية المرخصين
Direct Insurance Billing
WhatsApp verification & pre‑approval within 2 hours
تحقق من تغطية التأمين عبر واتساب +971 54 548 8731
Test Overview & Comparison
This Next‑Generation Sequencing (NGS) test screens the entire TUBGCP6 gene for pathogenic variants linked to autosomal recessive microcephaly, chorioretinopathy, and intellectual disability.
اختبار جيني شامل يكشف طفرات جين TUBGCP6 المرتبطة بصغر الرأس واعتلال الشبكية المشيمية والإعاقة الذهنية.
| Feature | Our TUBGCP6 NGS Test | Closest Alternative (Single‑Gene / Panel) |
|---|---|---|
| Technology | NGS – complete gene sequencing & deletion/duplication analysis | Sanger sequencing or targeted microarray; may miss non‑coding variants |
| Turnaround Time | 3 – 4 Weeks | 4 – 8 Weeks |
| Sample Types | Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card) | Usually whole blood only |
| Coverage | All exons, flanking intronic regions, known deep intronic variants | May be limited to known point mutations |
| UAE DHA/MOHAP Compliance | Full – Federal Decree‑Law No. 41/2024, CDS Law 2026, PDPL ready | Varies; often lacks explicit pediatric consent mechanisms |
Physician Insight & Safety Protocol
“Clinical correlation with the patient’s phenotype and family history is paramount; a negative TUBGCP6 result does not exclude other genetic diagnoses. I strongly advise pre‑test and post‑test genetic counselling to ensure appropriate interpretation and family planning.”
— Dr. PRABHAKAR REDDY, DHA License 61713011
⚠️ Medication Warning
Do not discontinue any prescribed medication without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
- Acute febrile illness or unstable clinical condition at time of sampling
- Lack of informed consent; for minors, parental consent is mandatory per UAE CDS Law 2026
- Asymptomatic individuals seeking testing without prior genetic counselling
- Emergency Red Flag: If the patient has rapidly progressive neurological deterioration, seizures, or loss of vision, seek immediate emergency care – do not wait for genetic test results.
Patient FAQ & Clinical Guidance
1. How long does the TUBGCP6 genetic test take in the UAE, and what does the cost include?
Results are delivered in 3 to 4 weeks, covering full gene sequencing, variant interpretation, and a bilingual clinical report. تظهر النتائج خلال ٣ إلى ٤ أسابيع شاملة تفسير الطفرات وتقرير سريري ثنائي اللغة.
2. Can this test be done on newborns, and are there special requirements?
Yes, a simple dried blood spot on an FTA card or a tiny heel‑prick sample suffices; we strictly follow UAE neonatal consent regulations. نعم، يمكن استخدام بقعة دم جافة على بطاقة FTA مع التزامنا بقوانين الموافقة على فحوص حديثي الولادة في الإمارات.
3. What happens if the TUBGCP6 result is negative?
A negative report means no clinically significant variant was identified, but further testing by whole exome sequencing may be recommended. النتيجة السلبية تعني عدم وجود طفرة مرضية واضحة، وقد ننصح بتوسيع التحليل إلى الإكسوم الكامل.
Pre‑Test Preparation
- Provide a detailed clinical history of the patient, including dysmorphology notes.
- Mandatory genetic counselling session to draw a pedigree chart of family members affected with TUBGCP6‑related conditions.
- No fasting required; sample can be whole blood (EDTA tube), extracted DNA, or a single dried blood spot on an FTA card.
- Patients must not stop any prescribed medication before the test.
This fully complies with UAE Federal Decree‑Law No. 41 of 2024 (Art. 87) on genetic counselling, the Child Data Safety (CDS) Law 2026 for minors, and the UAE Personal Data Protection Law (PDPL). ISO 9001:2015 Certified (INT/EGQ/2509DA/3139). DHA facility license: 9834453.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians